AI CAPITAL INTELLIGENCE

夏尔巴医疗基金 | Institution profile

Institution at a glance

Sherpa Healthcare Partners is a specialist healthcare investor focused primarily on early- and growth-stage equity in Greater China, with selective investments in the United States and other markets. Its team covers biotech and pharmaceuticals, medical devices and diagnostics, and healthcare services.

Source verification date: · The firm’s US$1.9 billion and 160-company figures are stated as of September 30, 2024 and count team experience since 2011, including fund cycles before Sherpa was founded. They are not Sherpa-only AUM or returns. The funding database’s 2026 MindRank Series B row points to evidence of Sherpa leading a 2021 angel round and does not establish Series B participation.

Original source 1 · Original source 2 · Original source 3

Names follow their disclosed form. Descriptive English renderings of Chinese names are not verified legal names. Original quotations are shown in their source language.

Key facts

FoundedSherpa says it was founded in 2018.
Investment strategyValue-oriented early- and growth-stage healthcare equity investments, primarily in Greater China and selectively in the United States and other jurisdictions.
Focus areasBiotech and pharmaceuticals; medical technology and diagnostics; healthcare services.
Managing partnersThe firm’s website lists Cheng Xing, Xiangyu Ouyang and Daqing (Darren) Cai as Managing Partners.
Team experienceAs of September 30, 2024, the team said it had managed more than US$1.9 billion and worked with 160 portfolio companies since 2011, including earlier fund cycles.

Public record

Official contact details

Sources

  1. 1. Sherpa Healthcare Partners — Investment Focus
    Sherpa focuses on early- and growth-stage healthcare equity investments, primarily in Greater China and selectively in the U.S.
  2. 2. Sherpa Healthcare Partners — Team
    The website lists Cheng Xing, Xiangyu Ouyang and Daqing Cai as Managing Partners.
  3. 3. About Sherpa Healthcare Partners
    夏尔巴投资创立于2018年,专注生命科技、医药、器械诊断和医疗服务。Original Chinese-language excerpt
  4. 4. Sherpa Healthcare Partners — Team and Portfolio Statistics
    As of September 30, 2024, the team had managed over US$1.9 billion and worked with 160 portfolio companies since 2011.
  5. 5. MindRank secures US$52 million Series B financing — VCBeat
    in May 2021, it closed a RMB 45 million angel round led by Sherpa Medical Fund
  6. 6. Sherpa Healthcare Partners — Contact Details
    商业计划书联系邮箱:info@sherpahp.com。Original Chinese-language excerpt

Browse all source-backed profiles · View Chinese profile